Andrew Milat
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew Milat has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
- Ali Ben Charif
CubecXpert, Quebec City, Quebec, Canada
2 shared publications - France Légaré
Department of Family Medicine and Emergency Medicine, Université Laval, Quebec, Quebec, Canada
2 shared publications - Robert Kenneth Douglas McLean
International Development Research Centre, Ottawa, Canada
2 shared publications - Adrian Bauman
Prevention Research Collaboration, Sydney School of Public Health, The University of Sydney, Camperdown, NSW, Australia
1 shared publication - Amelie M. Achim
Faculté de Médecine, Université Laval
1 shared publication - Amédé Gogovor
Department of Family Medicine and Emergency Medicine, Faculty of Medicine, Université Laval, Quebec City, QC, Canada
1 shared publication
Latest Publications
- Open Access
- 12 March 2025
- Published by CSIRO Publishing in Public Health Research and Practice
- Vol. 35 (1)
Artificial intelligence and public health: prospects, hype and challenges
Objectives and importance of the study: Applications of artificial intelligence (AI) platforms and technologies to healthcare have been widely promoted as offering revolutionary improvements and efficiencies in clinical practice and health services organisation. Practical applications of AI in public health are now emerging and receiving similar attention. This paper provides an overview of the issues and examples of research that help separate the potential from the hype. Methods: Selective review and analysis of cross-section of relevant literature. Results: Great potential exists for the use of AI in public health practice and research. This includes immediate applications in improving health education and communication directly with the public, as well as great potential for the productive use of generative AI through chatbots and virtual assistants in health communication. AI also has applications in disease surveillance and public health science, for example in improving epidemic and pandemic early warning systems, in synthetic data generation, in sequential decision-making in uncertain conditions (reinforcement learning) and in disease risk prediction. Most published research examining these and other applications is at a fairly early stage, making it difficult to separate the probable benefits from the hype. This research is undoubtedly demonstrating great potential but also identifying challenges, for example in the quality and relevance of health information being produced by generative AI; in access, trust and use of the technology by different populations; and in the practical application of AI to support disease surveillance and public health science. There are real risks that current access and patterns of use may exacerbate existing inequities in health and that the orientation towards the personalisation of health advice may divert attention away from underlying social and economic determinants of health. Conclusions: Realising the potential of AI not only requires further research and experimentation but also careful consideration of its ethical implications and thoughtful regulation. This will ensure that advances in these technologies serve the best interests of individuals and communities worldwide and don’t exacerbate existing health inequalities.
- 12 March 2025
- Published by CSIRO Publishing in Public Health Research and Practice
- Vol. 35 (1)
Open AccessArtificial intelligence and public health: prospects, hype and challenges
Objectives and importance of the study: Applications of artificial intelligence (AI) platforms and technologies to healthcare have been widely promoted as offering revolutionary improvements and efficiencies in clinical practice and health services organisation. Practical applications of AI in public health are now emerging and receiving similar attention. This paper provides an overview of the issues and examples of research that help separate the potential from the hype. Methods: Selective review and analysis of cross-section of relevant literature. Results: Great potential exists for the use of AI in public health practice and research. This includes immediate applications in improving health education and communication directly with the public, as well as great potential for the productive use of generative AI through chatbots and virtual assistants in health communication. AI also has applications in disease surveillance and public health science, for example in improving epidemic and pandemic early warning systems, in synthetic data generation, in sequential decision-making in uncertain conditions (reinforcement learning) and in disease risk prediction. Most published research examining these and other applications is at a fairly early stage, making it difficult to separate the probable benefits from the hype. This research is undoubtedly demonstrating great potential but also identifying challenges, for example in the quality and relevance of health information being produced by generative AI; in access, trust and use of the technology by different populations; and in the practical application of AI to support disease surveillance and public health science. There are real risks that current access and patterns of use may exacerbate existing inequities in health and that the orientation towards the personalisation of health advice may divert attention away from underlying social and economic determinants of health. Conclusions: Realising the potential of AI not only requires further research and experimentation but also careful consideration of its ethical implications and thoughtful regulation. This will ensure that advances in these technologies serve the best interests of individuals and communities worldwide and don’t exacerbate existing health inequalities.
- Open Access
- 5 June 2024
- Published by Wiley in Health Expectations
- Vol. 27 (3) , e14086
Strategies for involving patients and the public in scaling initiatives in health and social services: A scoping review
Background: Scaling in health and social services (HSS) aims to increase the intended impact of proven effective interventions. Patient and public involvement (PPI) is critical for ensuring that scaling beneficiaries’ interests are served. We aimed to identify PPI strategies and their characteristics in the science and practice of scaling in HSS.Methods: In this scoping review, we included any scaling initiative in HSS that used PPI strategies and reported PPI methods and outcomes. We searched electronic databases (e.g., Medline) from inception to 5 February 2024, and grey literature (e.g., Google). Paired reviewers independently selected and extracted eligible reports. A narrative synthesis was performed and we used the PRISMA for Scoping Reviews and the Guidance for Reporting Involvement of Patients and the Public (GRIPP2).Findings: We included 110 unique reports out of 24,579 records. In the past 5 years, the evidence on PPI in scaling has increased faster than in any previous period. We found 236 mutually nonexclusive PPI strategies among 120 scaling initiatives. Twenty‐four initiatives did not target a specific country; but most of those that did so (n = 96) occurred in higher‐income countries (n = 51). Community‐based primary health care was the most frequent level of care (n = 103). Mostly, patients and the public were involved throughout all scaling phases (n = 46) and throughout the continuum of collaboration (n = 45); the most frequently reported ethical lens regarding the rationale for PPI was consequentialist‐utilitarian (n = 96). Few papers reported PPI recruitment processes (n = 31) or incentives used (n = 18). PPI strategies occurred mostly in direct care (n = 88). Patient and public education was the PPI strategy most reported (n = 31), followed by population consultations (n = 30).Conclusions: PPI in scaling is increasing in HSS. Further investigation is needed to better document the PPI experience in scaling and ensure that it occurs in a meaningful and equitable way.Patient and Public Contribution: Two patients were involved in this review. They shared decisions on review questions, data collection instruments, protocol design, and findings dissemination.Review Registration: Open Science Framework on 19 August 2020 (https://osf.io/zqpx7/).
- 5 June 2024
- Published by Wiley in Health Expectations
- Vol. 27 (3) , e14086
Open AccessStrategies for involving patients and the public in scaling initiatives in health and social services: A scoping review
Background: Scaling in health and social services (HSS) aims to increase the intended impact of proven effective interventions. Patient and public involvement (PPI) is critical for ensuring that scaling beneficiaries’ interests are served. We aimed to identify PPI strategies and their characteristics in the science and practice of scaling in HSS.Methods: In this scoping review, we included any scaling initiative in HSS that used PPI strategies and reported PPI methods and outcomes. We searched electronic databases (e.g., Medline) from inception to 5 February 2024, and grey literature (e.g., Google). Paired reviewers independently selected and extracted eligible reports. A narrative synthesis was performed and we used the PRISMA for Scoping Reviews and the Guidance for Reporting Involvement of Patients and the Public (GRIPP2).Findings: We included 110 unique reports out of 24,579 records. In the past 5 years, the evidence on PPI in scaling has increased faster than in any previous period. We found 236 mutually nonexclusive PPI strategies among 120 scaling initiatives. Twenty‐four initiatives did not target a specific country; but most of those that did so (n = 96) occurred in higher‐income countries (n = 51). Community‐based primary health care was the most frequent level of care (n = 103). Mostly, patients and the public were involved throughout all scaling phases (n = 46) and throughout the continuum of collaboration (n = 45); the most frequently reported ethical lens regarding the rationale for PPI was consequentialist‐utilitarian (n = 96). Few papers reported PPI recruitment processes (n = 31) or incentives used (n = 18). PPI strategies occurred mostly in direct care (n = 88). Patient and public education was the PPI strategy most reported (n = 31), followed by population consultations (n = 30).Conclusions: PPI in scaling is increasing in HSS. Further investigation is needed to better document the PPI experience in scaling and ensure that it occurs in a meaningful and equitable way.Patient and Public Contribution: Two patients were involved in this review. They shared decisions on review questions, data collection instruments, protocol design, and findings dissemination.Review Registration: Open Science Framework on 19 August 2020 (https://osf.io/zqpx7/).
- Open Access
- 16 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (7) , e37079
Informing the development of the SUCCEED reporting guideline for studies on the scaling of health interventions: A systematic review
Background: Quality reporting contributes to effective translation of health research in practice and policy. As an initial step in the development of a reporting guideline for scaling, the Standards for reporting stUdies of sCaling evidenCEd-informED interventions (SUCCEED), we performed a systematic review to identify relevant guidelines and compile a list of potential items. Methods: We conducted a systematic review according to Cochrane method guidelines. We searched the following databases: MEDLINE, Embase, PsycINFO, Cochrane Library, CINAHL, Web of Science, from their respective inceptions. We also searched websites of relevant organizations and Google. We included any document that provided instructions or recommendations, e.g., reporting guideline, checklist, guidance, framework, standard; could inform the design or reporting of scaling interventions; and related to the health sector. We extracted characteristics of the included guidelines and assessed their methodological quality using a 3-item internal validity assessment tool. We extracted all items from the guidelines and classified them according to the main sections of reporting guidelines (title, abstract, introduction, methods, results, discussion and other information). We performed a narrative synthesis based on descriptive statistics. Results: Of 7704 records screened (published between 1999 and 2019), we included 39 guidelines, from which data were extracted from 57 reports. Of the 39 guidelines, 17 were for designing scaling interventions and 22 for reporting implementation interventions. At least one female author was listed in 31 guidelines, and 21 first authors were female. None of the authors belonged to the patient stakeholder group. Only one guideline clearly identified a patient as having participated in the consensus process. More than half the guidelines (56%) had been developed using an evidence-based process. In total, 750 items were extracted from the 39 guidelines and distributed into the 7 main sections. Conclusion: Relevant items identified could inform the development of a reporting guideline for scaling studies of evidence-based health interventions. This and our assessment of guidelines could contribute to better reporting in the science and practice of scaling.
- 16 February 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (7) , e37079
Open AccessInforming the development of the SUCCEED reporting guideline for studies on the scaling of health interventions: A systematic review
Background: Quality reporting contributes to effective translation of health research in practice and policy. As an initial step in the development of a reporting guideline for scaling, the Standards for reporting stUdies of sCaling evidenCEd-informED interventions (SUCCEED), we performed a systematic review to identify relevant guidelines and compile a list of potential items. Methods: We conducted a systematic review according to Cochrane method guidelines. We searched the following databases: MEDLINE, Embase, PsycINFO, Cochrane Library, CINAHL, Web of Science, from their respective inceptions. We also searched websites of relevant organizations and Google. We included any document that provided instructions or recommendations, e.g., reporting guideline, checklist, guidance, framework, standard; could inform the design or reporting of scaling interventions; and related to the health sector. We extracted characteristics of the included guidelines and assessed their methodological quality using a 3-item internal validity assessment tool. We extracted all items from the guidelines and classified them according to the main sections of reporting guidelines (title, abstract, introduction, methods, results, discussion and other information). We performed a narrative synthesis based on descriptive statistics. Results: Of 7704 records screened (published between 1999 and 2019), we included 39 guidelines, from which data were extracted from 57 reports. Of the 39 guidelines, 17 were for designing scaling interventions and 22 for reporting implementation interventions. At least one female author was listed in 31 guidelines, and 21 first authors were female. None of the authors belonged to the patient stakeholder group. Only one guideline clearly identified a patient as having participated in the consensus process. More than half the guidelines (56%) had been developed using an evidence-based process. In total, 750 items were extracted from the 39 guidelines and distributed into the 7 main sections. Conclusion: Relevant items identified could inform the development of a reporting guideline for scaling studies of evidence-based health interventions. This and our assessment of guidelines could contribute to better reporting in the science and practice of scaling.
- Open Access
- 28 June 2018
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 16 (1) , 55
Does citation matter? Research citation in policy documents as an indicator of research impact – an Australian obesity policy case-study
Citation of research in policy documents has been suggested as an indicator of the potential longer-term impacts of research. We investigated the use of research citations in childhood obesity prevention policy documents from New South Wales (NSW), Australia, considering the feasibility and value of using research citation as a proxy measure of research impact. We examined childhood obesity policy documents produced between 2000 and 2015, extracting childhood obesity-related references and coding these according to reference type, geographical origin and type of research. A content analysis of the policy documents examined where and how research was cited in the documents and the context of citation for individual research publications. Over a quarter (28%) of the policy documents (n = 86) were not publicly available, almost two-thirds (63%) contained references, half (47%) cited obesity-related research and over a third (41%) of those containing references used unorthodox referencing styles, making reference extraction laborious. No patterns, in terms of the types of documents more likely to cite research, were observed and the number of obesity research publications cited per document was highly variable. In total, 263 peer-reviewed and 94 non-peer-reviewed obesity research publications were cited. Research was most commonly cited to support a policy argument or choice of solution. However, it was not always possible to determine how or why individual publications were cited or whether the cited research itself had influenced the policy process. Content analysis identified circumstances where research was mentioned or considered, but not directly cited. Citation of research in policy documents in this case did not always provide evidence that the cited research had influenced the policy process, only that it was accessible and relevant to the content of the policy document. Research citation across these public health policy documents varied greatly and is unlikely to be an accurate reflection of actual research use by the policy agencies involved. The links between citation and impact may be more easily drawn in specific policy areas or types of documents (e.g. clinical guidelines), where research appraisal feeds directly into policy recommendations.
- 28 June 2018
- Published by Springer Nature in Health Research Policy and Systems
- Vol. 16 (1) , 55
Open AccessDoes citation matter? Research citation in policy documents as an indicator of research impact – an Australian obesity policy case-study
Citation of research in policy documents has been suggested as an indicator of the potential longer-term impacts of research. We investigated the use of research citations in childhood obesity prevention policy documents from New South Wales (NSW), Australia, considering the feasibility and value of using research citation as a proxy measure of research impact. We examined childhood obesity policy documents produced between 2000 and 2015, extracting childhood obesity-related references and coding these according to reference type, geographical origin and type of research. A content analysis of the policy documents examined where and how research was cited in the documents and the context of citation for individual research publications. Over a quarter (28%) of the policy documents (n = 86) were not publicly available, almost two-thirds (63%) contained references, half (47%) cited obesity-related research and over a third (41%) of those containing references used unorthodox referencing styles, making reference extraction laborious. No patterns, in terms of the types of documents more likely to cite research, were observed and the number of obesity research publications cited per document was highly variable. In total, 263 peer-reviewed and 94 non-peer-reviewed obesity research publications were cited. Research was most commonly cited to support a policy argument or choice of solution. However, it was not always possible to determine how or why individual publications were cited or whether the cited research itself had influenced the policy process. Content analysis identified circumstances where research was mentioned or considered, but not directly cited. Citation of research in policy documents in this case did not always provide evidence that the cited research had influenced the policy process, only that it was accessible and relevant to the content of the policy document. Research citation across these public health policy documents varied greatly and is unlikely to be an accurate reflection of actual research use by the policy agencies involved. The links between citation and impact may be more easily drawn in specific policy areas or types of documents (e.g. clinical guidelines), where research appraisal feeds directly into policy recommendations.